Anti-STRC monoclonal antibody

Pre-made anti-STRC monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to STRC/STRC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1843-Ab-1/ GM-Tg-hg-IP1843-Ab-2Anti-Human STRC monoclonal antibodyHuman
GM-Tg-rg-IP1843-Ab-1/ GM-Tg-rg-IP1843-Ab-2Anti-Rat STRC monoclonal antibodyRat
GM-Tg-mg-IP1843-Ab-1/ GM-Tg-mg-IP1843-Ab-2Anti-Mouse STRC monoclonal antibodyMouse
GM-Tg-cynog-IP1843-Ab-1/ GM-Tg-cynog-IP1843-Ab-2Anti-Cynomolgus/ Rhesus macaque STRC monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1843-Ab-1/ GM-Tg-felg-IP1843-Ab-2Anti-Feline STRC monoclonal antibodyFeline
GM-Tg-cang-IP1843-Ab-1/ GM-Tg-cang-IP1843-Ab-2Anti-Canine STRC monoclonal antibodyCanine
GM-Tg-bovg-IP1843-Ab-1/ GM-Tg-bovg-IP1843-Ab-2Anti-Bovine STRC monoclonal antibodyBovine
GM-Tg-equg-IP1843-Ab-1/ GM-Tg-equg-IP1843-Ab-2Anti-Equine STRC monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1843-Ab-1/ GM-Tg-hg-IP1843-Ab-2; GM-Tg-rg-IP1843-Ab-1/ GM-Tg-rg-IP1843-Ab-2;
GM-Tg-mg-IP1843-Ab-1/ GM-Tg-mg-IP1843-Ab-2; GM-Tg-cynog-IP1843-Ab-1/ GM-Tg-cynog-IP1843-Ab-2;
GM-Tg-felg-IP1843-Ab-1/ GM-Tg-felg-IP1843-Ab-2; GM-Tg-cang-IP1843-Ab-1/ GM-Tg-cang-IP1843-Ab-2;
GM-Tg-bovg-IP1843-Ab-1/ GM-Tg-bovg-IP1843-Ab-2; GM-Tg-equg-IP1843-Ab-1/ GM-Tg-equg-IP1843-Ab-2
Products NameAnti-STRC monoclonal antibody
Formatmab
Target NameSTRC
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-STRC monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1843-Ag-1Recombinant multi-species STRC/ DFNB16 protein


    Target information

    Target IDGM-IP1843
    Target NameSTRC
    Gene ID161497,140476,691937,106996176,478278,101097733,528436,100056242
    Gene Symbol and SynonymsDFNB16,STRC
    Uniprot AccessionQ7RTU9
    Uniprot Entry NameSTRC_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000242866
    Target ClassificationN/A

    The target: STRC, gene name: STRC, also named as DFNB16. This gene encodes a protein that is associated with the hair bundle of the sensory hair cells in the inner ear. The hair bundle is composed of stiff microvilli called stereocilia and is involved with mechanoreception of sound waves. This gene is part of a tandem duplication on chromosome 15; the second copy is a pseudogene. Mutations in this gene cause autosomal recessive non-syndromic deafness. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.